Oxford Pharmascience Group (OXP)

 

OXP Share PerformanceMore

52 week high7.8900 20/05/16
52 week low1.5000 30/12/16
52 week change -1.7750 (-38.38%)
4 week volume24,950,644 02/03/17

Media for (OXP)

Presenter: Marcelo Bravo
25/01/2017
Presenter: Marcelo Bravo
13/09/2016

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Oxford Pharmascience narrows FY pretax loss

Oxford Pharmascience has roughly halved its FY pretax loss to 1.9m, from a loss of 3.9m a year earlier. Revenues totalled 7...

Final Results

RNS Number: 0823Z Oxford Pharmascience Group PLC 10 March 2017 10 March 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Final Results for the year ended 31 December 2016 Oxford Pharmascience Group plc (AIM: OXP), the speciality pharmaceutical company that redevelops medicines to make them better, safer and easie...

Notice of Results

RNS Number: 6745Y Oxford Pharmascience Group PLC 07 March 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Notice of Results Oxford Pharmascience, the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, expects to announce its annual audited results for the year en...

Company Update

RNS Number: 6402X Oxford Pharmascience Group PLC 23 February 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") OXPzero TM Ibuprofen - Positive Exploratory PK Study Data Oxford Pharmascience (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, p...

Oxford Pharmascience - Company update

Oxford Pharmascience issues company update

Oxford Pharmascience Group has provided a company update, the highlights of which are given below: - Dosing commen...

Company Update

RNS Number: 3020U Oxford Pharmascience Group PLC 17 January 2017 Technical, Clinical and Regulatory Update Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, provides the following update. Highlights Dosing commenced in the Phase I exploratory phar...

R&D Update

RNS Number: 6768O Oxford Pharmascience Group PLC 09 November 2016 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") R&D Update Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take provides the following update on the d...

Fundamental DataMore

EPS-0.11
Dividend yield0 %

Latest discussion posts More

Users' HoldingsMore

Users who hold Oxford Pharmascience Group also hold..
SIRIUS MINERALS15%
LLOYDS GRP.15%
GLAXOSMITHKLINE11%
TAYLOR WIMPEY9%
ID:ISIN:VGG9828A11949%

Codes & Symbols

ISINGB00B3LXPB43
SymbolsOXP, LSE:OXP, OXP.L, OXP:LN, LON:OXP, XLON:OXP